Disease: Ovarian low malignant potential tumor
- A clinical ultrasound algorithm to identify uterine sarcoma and smooth muscle tumors of uncertain malignant potential (STUMPs) in patients with myometrial lesions: the MYLUNAR Study
- A lactate metabolism-related signature predicting patient prognosis and immune microenvironment in ovarian cancer
- A novel defined programmed cell death related gene signature for predicting the prognosis of serous ovarian cancer
- A novel NIR fluorescent probe for enhanced beta-galactosidase detection and tumor imaging in ovarian cancer models
- A novel TCGA-validated programmed cell-death-related signature of ovarian cancer
- A prospective cohort study with serum anti-mullerian hormone levels change in patients undergoing uterine preservation after gestational trophoblastic neoplasia treatment with a methotrexate regimen
- Adherence to the low-fat diet pattern reduces the risk of lung cancer in American adults aged 55 years and above: a prospective cohort study
- Aetiology and management of persistent withdrawal occlusion in venous ports in oncology patients
- ALKBH5 modulates macrophages polarization in tumor microenvironment of ovarian cancer
- An extensive analysis of the prognostic and immune role of FOXO1 in various types of cancer
- Association of tumor immune infiltration and prognosis with homologous recombination repair genes mutations in early triple-negative breast cancer
- Atypical Endometriosis: A Comprehensive Systematic Review of Pathological Patterns and Diagnostic Challenges
- Body Mass Index and Risk of Female Reproductive System Tumors Subtypes: A Meta-Analysis Using Mendelian Randomization
- Cathepsins and cancer risk: a Mendelian randomization study
- Causal association between low vitamin D and polycystic ovary syndrome: a bidirectional mendelian randomization study
- Characterization of latently infected EBV+ antibody-secreting B cells isolated from ovarian tumors and malignant ascites
- Clinical and Genomic Landscape of RAS Mutations in Gynecologic Cancers
- Comprehensive next-generation sequencing identifies novel putative pathogenic or likely pathogenic germline variants in patients with concurrent tubo-ovarian and endometrial serous and endometrioid carcinomas or precursors
- Consensus and controversy in the management of paediatric and adult patients with ovarian immature teratoma: the Malignant Germ Cell International Consortium perspective
- Construction and validation of a prognostic model for overall survival time of patients with ovarian cancer by metabolism-related genes
- Construction of a prognostic model for ovarian cancer based on a comprehensive bioinformatics analysis of cuproptosis-associated long non-coding RNA signatures
- CRISPR/Cas9-based genome-wide screening for metastasis ability identifies FCGR1A regulating the metastatic process of ovarian cancer by targeting LSP1
- Deep fine-KNN classification of ovarian cancer subtypes using efficientNet-B0 extracted features: a comprehensive analysis
- Defining three ferroptosis-based molecular subtypes and developing a prognostic risk model for high-grade serous ovarian cancer
- Development of a high-throughput kinase activity platform using nanoLC-MS/MS with DIA approach for studying the anti-cancer mechanism of Taxol in ovarian cancer
- Drug resistance-related gene targets and molecular mechanisms in the A2780/Taxol-resistant epithelial ovarian cancer cell line
- Effects of joint screening for prostate, lung, colorectal, and ovarian cancer - results from a controlled trial
- Engineered CAR-T cells targeting the non-functional P2X purinoceptor 7 (P2X7) receptor as a novel treatment for ovarian cancer
- Enhanced amphiregulin exposure promotes modulation of the high grade serous ovarian cancer tumor immune microenvironment
- Enhancing precision targeting of ovarian cancer tumor cells in vivo through extracellular vesicle engineering
- Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer
- Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer
- FETPY: a Diiron(I) Thio-Carbyne Complex with Prominent Anticancer Activity In Vitro and In Vivo
- Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilities
- Folate Receptor Immunohistochemical Staining and Gynecologic Tumors: Initial Experience With 216 Cases
- Functional analysis and validation of oncodrive gene AP3S1 in ovarian cancer through filtering of mutation data from whole-exome sequencing
- Ghrelin Alleviates Inflammation, Insulin Resistance, and Reproductive Abnormalities in Mice with Polycystic Ovary Syndrome via the TLR4-NF-κB Signaling Pathway
- H-intensity scale score to estimate CSF GluN1 antibody titers with one-time immunostaining using a commercial assay
- Haemostatic Gene Expression in Cancer-Related Immunothrombosis: Contribution for Venous Thromboembolism and Ovarian Tumour Behaviour
- Health Care Utilization Prior to Ovarian Cancer Diagnosis in Publicly Insured Individuals in New York State
- High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma
- Histone modification-linked prognostic model for ovarian cancer reveals LBX2 as a novel growth promoter
- How Progesterone Receptor Expression Impacts Platinum Sensitivity in Ovarian Clear Cell Carcinoma: Insights from Clinical and Experimental Perspectives
- Human epidermal growth factor receptor-2 expression and subsequent dynamic changes in patients with ovarian cancer
- Identification and validation of genes associated with prognosis of cisplatin-resistant ovarian cancer
- Identification of a G-protein coupled receptor-related gene signature through bioinformatics analysis to construct a risk model for ovarian cancer prognosis
- Identification of necroptosis-related gene signatures for predicting the prognosis of ovarian cancer
- Identification of potentially actionable genetic variants in epithelial ovarian cancer: a retrospective cohort study
- Immune cell landscapes are associated with high-grade serous ovarian cancer survival
- Immune pathway through endometriosis to ovarian cancer
- In Silico Approach to Molecular Profiling of the Transition from Ovarian Epithelial Cells to Low-Grade Serous Ovarian Tumors for Targeted Therapeutic Insights
- Intraoperative frozen section evaluation of ovarian sex cord-stromal tumours and their mimics: a study of 121 cases with emphasis on potential diagnostic pitfalls
- Lactate drives the ESM1-SCD1 axis to inhibit the antitumor CD8(+) T-cell response by activating the Wnt/beta-catenin pathway in ovarian cancer cells and inducing cisplatin resistance
- Laser and Light-Based Therapies for Hirsutism Management in Women With Polycystic Ovarian Syndrome: A Systematic Review
- Lifetime Exposure to Cigarette Smoke, B-Cell Tumor Immune Infiltration, and Immunoglobulin Abundance in Ovarian Tumors
- Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)-induced phenotypes for platinum sensitivity and long-term survival in ovarian cancer-A study from the OVCAD consortium
- Low PDE4A expression promoted the progression of ovarian cancer by inducing Snail nuclear translocation
- Mesenteric cystic lymphangioma misdiagnosed as ovarian cyst in a 63-year-old female: A case report and review of literature
- Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer
- Metabolic characteristics of different phenotypes in reproductive-aged women with polycystic ovary syndrome
- Metabolic signature of follicular fluid in infertility-related diseases: a narrative review
- Metastasis of ovarian dysgerminoma in a postmenopausal patient: a rare case report
- MicroRNA 421 induces the formation of high-invasive cell subsets of ovarian cancer from low-invasive cell subsets mediated by exosomes by activating the PI3K/AKT pathway
- Molecular changes driving low-grade serous ovarian cancer and implications for treatment
- Mucinous cystadenoma and carcinoid tumor arising from an ovarian mature cystic teratoma in a 60 year-old patient: a case report
- Mucinous neoplasm of the appendix: A case report and review of literature
- New immune phenotypes for treatment response in high-grade serous ovarian carcinoma patients
- Ovarian carcinosarcoma is highly aggressive compared to other ovarian cancer histotypes
- Paired comparison of the analytical performance between the Oncomine Comprehensive Assay v3 and whole-exome sequencing of ovarian cancer tissue
- Perioperative outcomes and platinum resistant recurrence in patients undergoing systematic, protocol-based, total parietal peritonectomy during interval cytoreductive surgery for advanced ovarian cancer: results of the TORPEDO study
- Physician-reported patient involvement and treatment decisions in first-line ovarian cancer in the USA and Europe
- Population-specific validation and comparison of the performance of 77- and 313-variant polygenic risk scores for breast cancer risk prediction
- Potential exacerbation of polycystic ovary syndrome by saccharin sodium Via taste receptors in a letrozole rat model
- Prognostic and immunotherapeutic potential of regulatory T cell-associated signature in ovarian cancer
- Prostate Type Malignancies Arising in Ovarian Teratomas - A Report of Two Patients
- Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses
- Rare histopathological finding of ovarian pseudotumor: A case report
- Reevaluation of ovarian cyst fine-needle aspiration cytology: A 10-year institutional experience
- Relationships of SIGLEC family-related lncRNAs with clinical prognosis and tumor immune microenvironment in ovarian cancer
- RNA-binding protein THUMPD2 inhibits proliferation and promotes metastasis in epithelial ovarian cancer
- Sialyl-Tn serves as a potential therapeutic target for ovarian cancer
- Single-cell RNA sequencing reveals that MYBL2 in malignant epithelial cells is involved in the development and progression of ovarian cancer
- Single-molecule epiallelic profiling of DNA derived from routinely collected Pap specimens for noninvasive detection of ovarian cancer
- Single-sample gene set enrichment analysis reveals the clinical implications of immune-related genes in ovarian cancer
- Target-Triggered Aggregation of Modified E. coli for Diagnosis of Ovarian Cancer
- Targeting BRAF pathway in low-grade serous ovarian cancer
- The causal association between artificial sweeteners and the risk of cancer: a Mendelian randomization study
- The effect of tinzaparin on biomarkers in FIGO stages III-IV ovarian cancer patients undergoing neoadjuvant chemotherapy - the TABANETOC trial: study protocol for a randomized clinical multicenter trial
- The Impact of Mitochondria in Ovarian Cancer Cell Metabolism, Proliferation, and Metastasis
- The Integrated Bioinformatic Approach Reveals the Prognostic Significance of LRP1 Expression in Ovarian Cancer
- The intratumoral microbiota biomarkers for predicting survival and efficacy of immunotherapy in patients with ovarian serous cystadenocarcinoma
- The Predictive Role of Serum Lipid Levels, p53 and ki-67, According to Molecular Subtypes in Breast Cancer: A Randomized Clinical Study
- The prognostic value of MEK pathway-associated estrogen receptor signaling activity for female cancers
- ULK2 suppresses ovarian cancer cell migration and invasion by elevating IGFBP3
- Ultrasonographic and clinicopathological features of pelvic yolk sac tumors in women: a single-center retrospective analysis
- Ultrasound-responsive Bi(2)MoO(6)-MXene heterojunction as ferroptosis inducers for stimulating immunogenic cell death against ovarian cancer
- Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies
- Use of placental-derived mesenchymal stem cells to restore ovarian function and metabolic profile in a rat model of the polycystic ovarian syndrome
- Uterine Tumor Resembling Ovarian Sex-Cord Tumor (UTROSCT): A Rare Polyphenotypic Neoplasm
- VERU-111, an Orally Available Tubulin Inhibitor, Suppresses Ovarian Tumor Growth and Metastasis